Palisade Bio (PALI) Other Working Capital Changes (2010 - 2026)
Palisade Bio (PALI) reported Other Working Capital Changes of -$22000.0 for Q1 2026, up 31.25% year-over-year from -$16761.9 in Q1 2025, and down 117.32% on a QoQ basis from $127000.0 in Q3 2025.
Palisade Bio (PALI) has 17 years of Other Working Capital Changes data on file, last reported at -$22000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 31.25% year-over-year to -$22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71000.0 (up 1875.0% YoY) and the FY2025 annual result came in at $61000.0, changed N/A from the prior year.
- Other Working Capital Changes declined to -$22000.0 in Q1 2026 per PALI's latest filing, from $127000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $360000.0 in Q4 2022 and bottomed at -$472000.0 in Q2 2023.
- The 5-year median for Other Working Capital Changes is -$32000.0 (2025), against an average of -$28866.7.
- The widest annual swing landed in 2023, when Other Working Capital Changes tumbled 863.27%; it then surged 452.53% in 2024.
- Tracing PALI's Other Working Capital Changes over 5 years: stood at $360000.0 in 2022, then tumbled by 130.28% to -$109000.0 in 2023, then soared by 420.18% to $349000.0 in 2024, then slumped by 63.61% to $127000.0 in 2025, then plunged by 117.32% to -$22000.0 in 2026.
- Per Business Quant, the three latest PALI Other Working Capital Changes figures stand at -$22000.0 (Q1 2026), $127000.0 (Q3 2025), and -$34000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Jun 30, 2024 | -321,000.00 |
| Jun 30, 2024 | -321,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Sep 30, 2023 | -99,000.00 |
| Sep 30, 2023 | -99,000.00 |
| Jun 30, 2023 | -472,000.00 |
| Jun 30, 2023 | -472,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Dec 31, 2022 | 360,000.00 |
| Dec 31, 2022 | 360,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Dec 31, 2021 | -1.07 Mn |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -30,000.00 |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | -39,000.00 |
| Mar 31, 2021 | -39,000.00 |
| Sep 30, 2020 | 43,000.00 |
| Sep 30, 2020 | 43,000.00 |
| Jun 30, 2020 | 50,054.00 |
| Jun 30, 2020 | 50,054.00 |
| Mar 31, 2020 | -93,054.00 |
| Mar 31, 2020 | -93,054.00 |
| Dec 31, 2019 | -93,636.00 |
| Dec 31, 2019 | -93,636.00 |
| Sep 30, 2019 | 349,352.00 |
| Sep 30, 2019 | 349,352.00 |
| Jun 30, 2019 | -37,468.00 |
| Jun 30, 2019 | -37,468.00 |
| Mar 31, 2019 | -75,938.00 |
| Mar 31, 2019 | -75,938.00 |
| Dec 31, 2018 | -186,574.00 |
| Dec 31, 2018 | -186,574.00 |
| Sep 30, 2018 | 197,935.00 |
| Sep 30, 2018 | 197,935.00 |
| Jun 30, 2018 | -42,960.00 |
| Jun 30, 2018 | -42,960.00 |
| Mar 31, 2018 | -704.00 |
| Mar 31, 2018 | -704.00 |
| Dec 31, 2017 | -282,489.00 |
| Dec 31, 2017 | -282,489.00 |
| Sep 30, 2017 | -736.00 |
| Sep 30, 2017 | -736.00 |
| Jun 30, 2017 | -11,993.00 |
| Jun 30, 2017 | -11,993.00 |
| Mar 31, 2017 | -2,080.00 |
| Mar 31, 2017 | -2,080.00 |
| Dec 31, 2016 | -2,081.00 |
| Dec 31, 2016 | -2,081.00 |
| Sep 30, 2016 | 237,223.00 |
| Sep 30, 2016 | 237,223.00 |
| Jun 30, 2016 | -323,431.00 |
| Jun 30, 2016 | -323,431.00 |
| Mar 31, 2016 | -67,646.00 |
| Mar 31, 2016 | -67,646.00 |
| Dec 31, 2015 | -1.22 Mn |
| Dec 31, 2015 | -1.22 Mn |
| Sep 30, 2015 | 1.11 Mn |
| Sep 30, 2015 | 1.11 Mn |
| Jun 30, 2015 | -209,421.00 |
| Jun 30, 2015 | -209,421.00 |
| Mar 31, 2015 | 71,207.00 |
| Mar 31, 2015 | 71,207.00 |
| Dec 31, 2014 | -135,042.00 |
| Dec 31, 2014 | -135,042.00 |
| Sep 30, 2014 | 2,223.00 |
| Sep 30, 2014 | 2,223.00 |
| Jun 30, 2014 | -123,407.00 |
| Jun 30, 2014 | -123,407.00 |
| Mar 31, 2014 | 64,963.00 |
| Mar 31, 2014 | 64,963.00 |
| Dec 31, 2013 | -116,819.00 |
| Dec 31, 2013 | -116,819.00 |
| Sep 30, 2013 | -3,231.00 |
| Sep 30, 2013 | -3,231.00 |
| Jun 30, 2013 | -2,815.00 |
| Jun 30, 2013 | -2,815.00 |
| Mar 31, 2013 | -2,605.00 |
| Mar 31, 2013 | -2,605.00 |
| Dec 31, 2012 | -187,867.00 |
| Dec 31, 2012 | -187,867.00 |
| Sep 30, 2012 | 159,117.00 |
| Sep 30, 2012 | 159,117.00 |
| Jun 30, 2012 | -135,367.00 |
| Jun 30, 2012 | -135,367.00 |
| Dec 31, 2011 | -374,960.00 |
| Dec 31, 2011 | -374,960.00 |
| Sep 30, 2011 | 368,717.00 |
| Sep 30, 2011 | 368,717.00 |
| Jun 30, 2011 | 6,243.00 |
| Jun 30, 2011 | 6,243.00 |
| Mar 31, 2011 | -322,127.00 |
| Mar 31, 2011 | -322,127.00 |
| Dec 31, 2010 | 288,553.00 |
| Dec 31, 2010 | 288,553.00 |
| Sep 30, 2010 | 45,040.00 |
| Sep 30, 2010 | 45,040.00 |